Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota

• Main Authors: Jing-Yi Hou (Author), He Xu (Author), Guang-Zhao Cao (Author), Liang-Liang Tian (Author), Li-Han Wang (Author), Nai-Qiang Zhu (Author), Jing-Jing Zhang (Author), Hong-Jun Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dengzhan Shengmai (DZSM), a traditional Chinese medicine formulation, has been administered extensively to elderly individuals with cognitive impairment (CI). However, the underlying mechanisms by which Dengzhan Shengmai improves cognitive impairment remains unknown. This study aimed to elucidate th...